A Double-Blind, Randomized, Placebo-Controlled, 5-Arm Titration Study to Evaluate the Efficacy and Safety of TAK-491 When Compared with Valsartan and Olmesartan in Subjects with Essential Hypertension
A Double-Blind, Randomized, Placebo-Controlled, 5-Arm Titration Study to Evaluate the Efficacy and Safety of TAK-491 When Compared with Valsartan and Olmesartan in Subjects with Essential Hypertension
© 2022 Latin Clinical Trial Center.
All Rights Reserved.
Powered By Millennial Networks